Current Clinical Trials

CATT and CATT FS

Palmetto Retina - Thursday, July 24, 2014
Sponsor: University of Pennsylvania Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Follow-Up Study (CATT FS) Read More

LT1009-Oph-003 (Nexus)

Palmetto Retina - Thursday, July 24, 2014
Sponsor: Lpath, Inc. A Phase 2A, Multi-center, Masked, Randomized, Comparator-Controlled study evaluating iSONEP (Sonepcizumab [LT1009]) as either monotherapy to Lucentis, Avastin or Eylea ver Read More

Protocol PAN-01-101

Palmetto Retina - Thursday, July 24, 2014
Sponsor: Pan Optica A Phase 1 Open-Label, Multi-Center Trial with Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients with Neovascular Age-Rel Read More

OPH1003A

Palmetto Retina - Thursday, July 24, 2014
Sponsor: Ophthotech A Phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous administration of Fovista (Anti PDGF-B Pegylated Aptamer) admini Read More

TREX AMD

Palmetto Retina - Thursday, July 24, 2014
Sponsor: Genentech A phase IIIb, multicenter, randomized, controlled study of the safety, tolerability and efficacy of intravitreal injections of 0.5mg ranibizumab given monthly compared to a  Read More

VGFTe-AMD-1124

Palmetto Retina - Thursday, July 24, 2014
An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients with Neovascular Age-Related Macular  Read More

0

Combined Years of Practice

0

Operations Performed

0

Clinical Trials Participated

0

Offices

Our Physicians

Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.

Please Contact Us For More Information

(803) 931-0077 | (888) 931-0077